ORMP
Oramed Pharmaceuticals Inc
4.70$
+1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Oramed Pharmaceuticals Inc (ORMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -0.2 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.5 | -1.3 | -1.5 | 2.1 | -7.1 | -1.9 | -3.5 | -3.6 | -2.0 | -0.5 | -2.9 | -0.2 | -5.6 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.9 | 1.4 | 1.3 | 1.2 | 0.3 | 1.2 | 2.2 | 0.8 | 0.7 | 2.3 | 1.7 | 1.4 | 6.1 | |
| 1.8 | -0.4 | -0.6 | 2.2 | 1.6 | 0.0 | -1.6 | -2.7 | 9.8 | 0.6 | 7.8 | 1.9 | 20 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.2 | |
| -72 | 29 | 30 | 94 | -34 | 16 | 24 | -55 | 39 | -1.7 | -19 | 4.3 | 22 | |
| – | – | – | – | – | – | 0.0 | 0.0 | – | 11 | 10 | 0.1 | – | |
| 0.0 | – | – | – | -1.3 | -1.2 | – | -0.4 | -0.4 | -4.0 | – | – | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 72 | -24 | -19 | -30 | -1.5 | -1.4 | 0.0 | -0.4 | -0.4 | -4.0 | -10 | -1.9 | -17 | |
| -1.3 | 3.6 | 9.5 | 66 | -43 | 12 | 20 | -59 | 36 | -6.2 | -33 | 2.0 | -0.6 | |
| -0.6 | -1.3 | -1.5 | 2.1 | -7.1 | -1.9 | -3.5 | -3.6 | -2.0 | -0.3 | -2.9 | -0.2 | -5.4 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.